Philippe Bedard, MD, FRCPC

Follow Dr. Bedard:
Dr. Bedard received his medical degree from the University of Toronto where he was awarded the Cody Academic Silver Medal. He completed his Internal Medicine and Medical Oncology specialty training at the University of Toronto. He received additional fellowship training in clinical and translational breast cancer research at the Breast International Group (BIG).
 
In recognition of his research excellence, Dr. Bedard received the 2012 Career Development Award from the the Conquer Cancer Foundation of the American Society of Clinical Oncology.
Dr. Bedard has a clinical practice and a research program. His clinical practice includes the treatment of patients with breast and testicular cancers. His research program involves early phase clinical trials with novel cancer drug treatments. These emerging treatments include immunotherapy and the personalization of cancer treatment based upon the results of testing for DNA mutations within tumor cells.
 
As a member of the Steering Committee for the AACR-GENIE project, Dr. Bedard is contributing to this international data-sharing initiative, which links cancer genomic data with clinical outcomes from tens of thousands of cancer patients treated at leading international institutions.
Genes (Basel). 2019 May 10;10(5):
Zazuli Z, Otten LS, Drögemöller BI, Medeiros M, Monzon JG, Wright GEB, Kollmannsberger CK, Bedard PL, Chen Z, Gelmon KA, McGoldrick N, Kitchlu A, Vijverberg SJH, Masereeuw R, Ross CJD, Liu G, Carleton BC, Maitland-van der Zee AH
Clin Oncol (R Coll Radiol). 2019 May 02;:
Raphael MJ, Wei X, Karim S, Robinson AG, Bedard PL, Booth CM
J Immunother Cancer. 2019 Mar 13;7(1):72
Clouthier DL, Lien SC, Yang SYC, Nguyen LT, Manem VSK, Gray D, Ryczko M, Razak ARA, Lewin J, Lheureux S, Colombo I, Bedard PL, Cescon D, Spreafico A, Butler MO, Hansen AR, Jang RW, Ghai S, Weinreb I, Sotov V, Gadalla R, Noamani B, Guo M, Elston S,...
Oncologist. 2019 Mar 04;:
Tan T, Rheaume M, Wang L, Chow H, Spreafico A, Hansen AR, Razak ARA, Siu LL, Bedard PL
J Clin Oncol. 2019 Feb 25;:JCO1801250
Hamilton RJ, Nayan M, Anson-Cartwright L, Atenafu EG, Bedard PL, Hansen A, Chung P, Warde P, Sweet J, O'Malley M, Sturgeon J, Jewett MAS
Gynecol Oncol. 2019 May;153(2):304-311
Rodriguez-Freixinos V, Lheureux S, Mandilaras V, Clarke B, Dhani NC, Mackay H, Butler MO, Wang L, Siu LL, Kamel-Reid S, Stockley T, Bedard PL, Oza AM
Cancer. 2019 Feb 15;:
Kanjanapan Y, Day D, Wang L, Al-Sawaihey H, Abbas E, Namini A, Siu LL, Hansen A, Razak AA, Spreafico A, Leighl N, Joshua AM, Butler MO, Hogg D, Chappell MA, Soultani L, Chow K, Boujos S, Bedard PL
J Immunother Cancer. 2019 Feb 13;7(1):46
Berry S, Giraldo N, Nguyen P, Green B, Xu H, Ogurtsova A, Soni A, Succaria F, Wang D, Roberts C, Stein J, Engle E, Pardoll D, Anders R, Cottrell T, Taube JM, Tran B, Voskoboynik M, Kuo J, Bang YL, Chung HC, Ahn MJ, Kim SW, Perera A, Freeman D, Achour I...
Oncologist. 2019 Feb 06;:
Shepshelovich D, McDonald K, Spreafico A, Razak ARA, Bedard PL, Siu LL, Minasian L, Hansen AR
Ann Oncol. 2019 Jan 31;:
Condorelli R, Mosele F, Verret B, Bachelot T, Bedard PL, Cortes J, Hyman DM, Juric D, Krop I, Bieche I, Saura C, Sotiriou C, Cardoso F, Loibl S, Andre F, Turner NC

Pages


 

Associate Professor, Faculty of Medicine, University of Toronto
Member, Steering Committee, American Association for Cancer Research (AACR) Genomics, Evidence, Neoplasia, Information, Exchange (GENIE) Project
Staff Medical Oncologist, Division of Medical Oncology, Princess Margaret Cancer Centre
Fellowship Director, Bras Drug Development Program, Princess Margaret Cancer Centre
Clinical Director, Cancer Genomics Program, Princess Margaret Cancer Centre